Published in Cell Death Dis on December 12, 2013
miR-34: from bench to bedside. Oncotarget (2014) 1.59
Anti-tumoral effect of desmethylclomipramine in lung cancer stem cells. Oncotarget (2015) 0.90
MiR-138 Suppresses Cell Proliferation by Targeting Bag-1 in Gallbladder Carcinoma. PLoS One (2015) 0.90
miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways. Oncotarget (2016) 0.89
KMTase Set7/9 is a critical regulator of E2F1 activity upon genotoxic stress. Cell Death Differ (2014) 0.89
DNA damage modulates interactions between microRNAs and the 26S proteasome. Oncotarget (2014) 0.83
KMT Set7/9 affects genotoxic stress response via the Mdm2 axis. Oncotarget (2015) 0.82
Identification of a new target of miR-16, Vacuolar Protein Sorting 4a. PLoS One (2014) 0.82
Mutant p53 induces EZH2 expression and promotes epithelial-mesenchymal transition by disrupting p68-Drosha complex assembly and attenuating miR-26a processing. Oncotarget (2015) 0.80
Mini but mighty: microRNAs in the pathobiology of periodontal disease. Periodontol 2000 (2015) 0.80
Human EHMT2/G9a activates p53 through methylation-independent mechanism. Oncogene (2016) 0.79
Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosis. Cell Death Dis (2015) 0.79
The p53 tetramer shows an induced-fit interaction of the C-terminal domain with the DNA-binding domain. Oncogene (2015) 0.78
Polypharmacology of small molecules targeting the ubiquitin-proteasome and ubiquitin-like systems. Oncotarget (2015) 0.78
MicroRNAs in Hyperglycemia Induced Endothelial Cell Dysfunction. Int J Mol Sci (2016) 0.77
Systematic analysis of the p53-related microRNAs in breast cancer revealing their essential roles in the cell cycle. Oncol Lett (2015) 0.76
CHK1 regulates NF-κB signaling upon DNA damage in p53- deficient cells and associated tumor-derived microvesicles. Oncotarget (2016) 0.76
Genome-Wide Scleral Micro- and Messenger-RNA Regulation During Myopia Development in the Mouse. Invest Ophthalmol Vis Sci (2016) 0.75
Herpesvirus saimiri MicroRNAs Preferentially Target Host Cell Cycle Regulators. J Virol (2015) 0.75
Sustained expression of miR-26a promotes chromosomal instability and tumorigenesis through regulation of CHFR. Nucleic Acids Res (2017) 0.75
One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy. Oncotarget (2017) 0.75
Induction of Macrophage Function in Human THP-1 Cells Is Associated with Rewiring of MAPK Signaling and Activation of MAP3K7 (TAK1) Protein Kinase. Front Cell Dev Biol (2016) 0.75
MicroRNA 26a (miR-26a)/KLF4 and CREB-C/EBPβ regulate innate immune signaling, the polarization of macrophages and the trafficking of Mycobacterium tuberculosis to lysosomes during infection. PLoS Pathog (2017) 0.75
Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapy. Cell Death Dis (2016) 0.75
Effect of SMYD3 on the microRNA expression profile of MCF-7 breast cancer cells. Oncol Lett (2017) 0.75
Synaptotagmin-7 is overexpressed in hepatocellular carcinoma and regulates hepatocellular carcinoma cell proliferation via Chk1-p53 signaling. Onco Targets Ther (2017) 0.75
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (2002) 32.26
Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell (1995) 12.39
Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev (2000) 11.49
Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell (2009) 11.10
Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer (2009) 9.26
Modulation of microRNA processing by p53. Nature (2009) 7.88
A microRNA signature of hypoxia. Mol Cell Biol (2006) 7.24
14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell (1997) 7.20
Regulation of the G2/M transition by p53. Oncogene (2001) 7.02
p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res (1995) 6.66
Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol (2007) 6.43
The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med (2008) 5.74
The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev (2000) 5.72
Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science (1997) 4.97
Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression. Cell (2011) 4.74
Retracted DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs. Nat Cell Biol (2007) 4.45
Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Cell (2012) 4.09
p53 enters the microRNA world. Cancer Cell (2007) 3.78
Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature (2012) 3.77
miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res (2008) 3.19
MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat Rev Cancer (2012) 2.78
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin Cancer Res (2006) 2.72
p53: at the crossroads of molecular carcinogenesis and risk assessment. Science (1993) 2.54
G2 checkpoint abrogators as anticancer drugs. Mol Cancer Ther (2004) 2.50
miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Res (2009) 2.39
p53 down-regulates CHK1 through p21 and the retinoblastoma protein. Mol Cell Biol (2001) 1.93
Cooperative effects of genes controlling the G(2)/M checkpoint. Genes Dev (2000) 1.80
The impact of p53 and p73 on aneuploidy and cancer. Trends Cell Biol (2008) 1.76
Methylation-acetylation interplay activates p53 in response to DNA damage. Mol Cell Biol (2007) 1.75
p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs. Proc Natl Acad Sci U S A (2012) 1.71
The GADD45 inhibition of Cdc2 kinase correlates with GADD45-mediated growth suppression. J Biol Chem (2000) 1.62
BioProfiling.de: analytical web portal for high-throughput cell biology. Nucleic Acids Res (2011) 1.60
Reciprocal influence of the p53 and the hypoxic pathways. Cell Death Dis (2011) 1.60
MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E. Mol Cancer Res (2011) 1.53
26S proteasome exhibits endoribonuclease activity controlled by extra-cellular stimuli. Cell Cycle (2010) 1.48
Drosophila Wee1 kinase regulates Cdk1 and mitotic entry during embryogenesis. Curr Biol (2004) 1.45
RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies. Proc Natl Acad Sci U S A (2004) 1.39
Forced activation of Cdk1 via wee1 inhibition impairs homologous recombination. Oncogene (2012) 1.31
miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs. Breast Cancer Res (2013) 1.29
How many ways to die? How many different models of cell death? Cell Death Differ (2005) 1.21
PPISURV: a novel bioinformatics tool for uncovering the hidden role of specific genes in cancer survival outcome. Oncogene (2013) 1.21
MIRUMIR: an online tool to test microRNAs as biomarkers to predict survival in cancer using multiple clinical data sets. Cell Death Differ (2012) 1.17
Regulation of p73 activity by post-translational modifications. Cell Death Dis (2012) 1.12
Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family. Cancer Res (2012) 1.11
Lysine methylation goes global. Cell Cycle (2006) 1.03
Negative regulation of Wee1 expression and Cdc2 phosphorylation during p53-mediated growth arrest and apoptosis. Cancer Res (1998) 1.02
MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs. Cell Death Differ (2011) 0.96
p53: 25 years of research and more questions to answer. Cell Death Differ (2003) 0.94
DNA damage-induced ubiquitylation of proteasome controls its proteolytic activity. Oncotarget (2013) 0.92
Role of proteasomes in transcription and their regulation by covalent modifications. Front Biosci (2008) 0.92
The microRNA and p53 families join forces against cancer. Cell Death Differ (2010) 0.91
Pharmacological activation of a novel p53-dependent S-phase checkpoint involving CHK-1. Cell Death Dis (2011) 0.89
IL-7Rα deficiency in p53null mice exacerbates thymocyte telomere erosion and lymphomagenesis. Cell Death Differ (2012) 0.86
Proteomic analysis of the 20S proteasome (PSMA3)-interacting proteins reveals a functional link between the proteasome and mRNA metabolism. Biochem Biophys Res Commun (2011) 0.82
The paths to death and differentiation. Cell Death Differ (2011) 0.81
PRAP1 is a novel executor of p53-dependent mechanisms in cell survival after DNA damage. Cell Death Dis (2012) 0.81
KMTase Set7/9 is a critical regulator of E2F1 activity upon genotoxic stress. Cell Death Differ (2014) 0.89